Related references
Note: Only part of the references are listed.An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Tyrosine Kinase Inhibitors Are Potent Acute Pulmonary Vasodilators in Rats
Kohtaro Abe et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Sorafenib Inhibits Transforming Growth Factor β1-Mediated Epithelial-Mesenchymal Transition and Apoptosis in Mouse Hepatocytes
Yue-Lei Chen et al.
HEPATOLOGY (2011)
Idiopathic pulmonary fibrosis
Talmadge E. King et al.
LANCET (2011)
Imatinib Treatment for Idiopathic Pulmonary Fibrosis Randomized Placebo-controlled Trial Results
Craig E. Daniels et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology
C. Vancheri et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis
Yan Wang et al.
JOURNAL OF HEPATOLOGY (2010)
Methylation determines fibroblast activation and fibrogenesis in the kidney
Wibke Bechtel et al.
NATURE MEDICINE (2010)
Contribution of Epithelial-derived Fibroblasts to Bleomycin-induced Lung Fibrosis
Harikrishna Tanjore et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Beneficial Effects of Sorafenib on Splanchnic, Intrahepatic, and Portocollateral Circulations in Portal Hypertensive and Cirrhotic Rats
Marc Mejias et al.
HEPATOLOGY (2009)
Smad6 Inhibits the Transcriptional Activity of Tbx6 by Mediating Its Degradation
Yue-Lei Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats
Thomas Reiberger et al.
JOURNAL OF HEPATOLOGY (2009)
Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis
Jing Yang et al.
DEVELOPMENTAL CELL (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats
Snia Tugues et al.
HEPATOLOGY (2007)
Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis
N. I. Chaudhary et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models
Yong S. Chang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Snail is required for transforming growth factor-β-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway
Hee Jun Cho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an α-smooth muscle actin-Cre transgenic mouse
Zhuang Wu et al.
RESPIRATORY RESEARCH (2007)
Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis
Markus Neef et al.
JOURNAL OF HEPATOLOGY (2006)
Incidence and prevalence of idiopathic pulmonary fibrosis
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix
Kevin K. Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Mechanisms of drug inhibition of signalling molecules
Judith S. Sebolt-Leopold et al.
NATURE (2006)
Dominant negative mutation of the TGF-β receptor blocks hypoxia-induced pulmonary vascular remodeling
YF Chen et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
TGF-β and epithelial-to-mesenchymal transitions
J Zavadil et al.
ONCOGENE (2005)
TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT) -: art. no. 56
H Kasai et al.
RESPIRATORY RESEARCH (2005)
Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-ß1 -: Potential role in idiopathic pulmonary fibrosis
BC Willis et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation
SF Cheng et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Evidence that fibroblasts derive from epithelium during tissue fibrosis
M Iwano et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Regulation of the effects of TGF-β1 by activation of latent TGF-β1 and differential expression of TGF-β receptors (TβR-I and TβR-II) in idiopathic pulmonary fibrosis
N Khalil et al.
THORAX (2001)
Mechanisms of disease:: Role of transforming growth factor β in human disease.
GC Blobe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
